Z-0334-2016 Class II Terminated

Recalled by Becton, Dickinson And Company, BD Biosciences — San Jose, CA

FDA device recall Z-0334-2016 was initiated by Becton, Dickinson And Company, BD Biosciences on Oct 30, 2015 and is designated Class II. Reason for recall: Three lots of CD64 (MD22) are contaminated with CD4 antibody. The recall status is terminated (terminated May 27, 2016). Affected quantity: 23 vials.

Recall details

Product Type
Devices
Report Date
Dec 2, 2015
Initiation Date
Oct 30, 2015
Termination Date
May 27, 2016
Voluntary/Mandated
Voluntary: Firm initiated
Product Quantity
23 vials

Product description

BD CD64 APC-R700; Analyte Specific Reagent; Model 657701; Lot No. 4344945, 5037611 and 5063945. Hematology - used as analyte specific reagent - contamination leads to possibility of unexpected staining pattern.

Reason for recall

Three lots of CD64 (MD22) are contaminated with CD4 antibody.

Distribution pattern

Distributed in the states of FL, WA, PA, IL, GA, RI, TX, ND, and IA.

Code information

Model 657701; Lot No. 4344945, 5037611, both with expiry date of 31 DEC 2015; and 5063945 with expiry dte of 29 FEB 2016.

Source

Dataset
openFDA device recall enforcement reports
FDA record
This recall in openFDA (JSON)
Enforcement Report
Search FDA's Enforcement Report for Z-0334-2016
openFDA file date
Nov 16, 2026
Loaded by RegDataLab
Nov 17, 2026

These dates say when openFDA published the data file and when RegDataLab last loaded it.

Source: openFDA record for Z-0334-2016. Report a data issue: hello@regdatalab.com.